James C Sisson

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi request reprint Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Thyroid 22:430-6. 2012
  2. ncbi request reprint Courses of malignant pheochromocytoma: implications for therapy
    James C Sisson
    Division of Nuclear Medicine, UH B1 G505D, Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48109 0028, and Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    Ann N Y Acad Sci 1073:505-11. 2006
  3. doi request reprint Radioiodine therapy and Graves' ophthalmopathy
    James C Sisson
    Nuclear Medicine Division, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0028, USA
    J Nucl Med 49:923-30. 2008
  4. pmc First description of parathyroid disease in multiple endocrine neoplasia 2A syndrome
    James C Sisson
    Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, UH B1 G505D, Ann Arbor, MI 48109 0028, USA
    Endocr Pathol 19:289-93. 2008
  5. pmc Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine
    James C Sisson
    Division of Nuclear Medicine and Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0028, USA
    Thyroid 19:297-303. 2009
  6. doi request reprint Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    Thyroid 21:335-46. 2011
  7. ncbi request reprint Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    J Nucl Med 44:898-903. 2003
  8. ncbi request reprint Radiopharmaceutical treatment of pheochromocytomas
    James C Sisson
    University of Michigan Health System, Ann Arbor, MI 48109 0028, USA
    Ann N Y Acad Sci 970:54-60. 2002
  9. ncbi request reprint The so-called stunning of thyroid tissue
    James C Sisson
    Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, Ann Arbor, 48109 0028, USA
    J Nucl Med 47:1406-12. 2006
  10. pmc Variation in the management of thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 98:2001-8. 2013

Detail Information

Publications25

  1. doi request reprint Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Thyroid 22:430-6. 2012
    ..A genetic mutation was hypothesized. Possible previously described genetic mutations were explored...
  2. ncbi request reprint Courses of malignant pheochromocytoma: implications for therapy
    James C Sisson
    Division of Nuclear Medicine, UH B1 G505D, Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48109 0028, and Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    Ann N Y Acad Sci 1073:505-11. 2006
    ..The role of 131I-MIBG therapy in longevity is uncertain, but this radiopharmaceutical reduces evidence of tumors in some patients. Criteria for selecting patients who will benefit from treatment remain to be determined...
  3. doi request reprint Radioiodine therapy and Graves' ophthalmopathy
    James C Sisson
    Nuclear Medicine Division, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0028, USA
    J Nucl Med 49:923-30. 2008
    ..We sought to determine the rates of appearance or increase in manifestations of GO in American patients treated with radioiodine for hyperthyroidism...
  4. pmc First description of parathyroid disease in multiple endocrine neoplasia 2A syndrome
    James C Sisson
    Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, UH B1 G505D, Ann Arbor, MI 48109 0028, USA
    Endocr Pathol 19:289-93. 2008
    ..The initial report of the proband preceded the publications defining both MTC and MEN 2A. The values of in-depth family histories and genetic analyses are exemplified...
  5. pmc Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine
    James C Sisson
    Division of Nuclear Medicine and Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0028, USA
    Thyroid 19:297-303. 2009
    ..A patient with an enlarging metastasis of thyroid carcinoma to the skull that was impinging on the brain illustrates diagnostic and therapeutic strategies applicable to the treatment of metastatic carcinoma...
  6. doi request reprint Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    Thyroid 21:335-46. 2011
    ..The task force was constituted so as to obtain advice, experience, and methods from relevant medical specialties and disciplines...
  7. ncbi request reprint Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    J Nucl Med 44:898-903. 2003
    ..If a broad range of body retentions occurs among patients, then high and low retentions will be a basis for modifying the usual prescriptions for (131)I to ensure safety and increase efficacy...
  8. ncbi request reprint Radiopharmaceutical treatment of pheochromocytomas
    James C Sisson
    University of Michigan Health System, Ann Arbor, MI 48109 0028, USA
    Ann N Y Acad Sci 970:54-60. 2002
    ..Nevertheless, selective radiation from 131-I MIBG or a similar radiopharmaceutical could play a valuable role in treatments that combine several types of attacks on this recalcitrant malignancy...
  9. ncbi request reprint The so-called stunning of thyroid tissue
    James C Sisson
    Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, Ann Arbor, 48109 0028, USA
    J Nucl Med 47:1406-12. 2006
    ..We hypothesized that stunning arose from the early effects of the therapeutic dose of (131)I and that the initial uptake of (131)I, observed within the first day, was not impaired by the diagnostic dose...
  10. pmc Variation in the management of thyroid cancer
    Megan R Haymart
    Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 98:2001-8. 2013
    ..Little is known about practice patterns in thyroid cancer, a cancer that is increasing in incidence...
  11. ncbi request reprint Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
    Judiann Miskulin
    Department of Surgery, University of Michigan, 1500 E Medical Center Drive, Taubman Center TC2920H, Ann Arbor, MI 48109 0331, USA
    Surgery 134:918-22; discussion 922-3. 2003
    ..We sought to determine the role of (123)I MIBG scintigraphy in this apparently routine preoperative setting. Our hypothesis was that (123)I MIBG would provide additional preoperative information that could modify operative intervention...
  12. doi request reprint Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT
    Ka Kit Wong
    Division of Nuclear Medicine, University of Michigan Medical Center, B1G505G University Hospital, 1500 E Medical Center Dr, Ann Arbor, MI 48109 5028, USA
    AJR Am J Roentgenol 195:730-6. 2010
    ....
  13. ncbi request reprint Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma
    Gregory A Yanik
    Blood and Marrow Stem Cell Transplantation Program, Division of Pediatric Hematology Oncology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    J Clin Oncol 20:2142-9. 2002
    ..A pilot study was performed to examine the feasibility of a novel regimen combining (131)I-MIBG and myeloablative chemotherapy with autologous stem-cell rescue...
  14. ncbi request reprint Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature
    Anca M Avram
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical Center, 1500 East Medical Center Drive, UH B1G 505D, Ann Arbor, Michigan 48109 0028, USA
    J Clin Endocrinol Metab 89:5303-7. 2004
    ..Occasionally such metastases may respond to (131)I therapy or external beam radiation...
  15. ncbi request reprint Current trends in functional imaging of pheochromocytomas and paragangliomas
    Barry L Shulkin
    Division of Nuclear Medicine, Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA, and Department of Pharmacology, Medical School, University of Patras, Rion, Greece
    Ann N Y Acad Sci 1073:374-82. 2006
    ..In an overview of the available nuclear medicine modalities, we summarize the accumulated experience and recommend when functional imaging should be applied to patients with pheochromocytoma/paraganglioma...
  16. ncbi request reprint Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy
    David Axelrod
    Department of Surgery, University of Michigan Medical School, Ann Arbor, USA
    Arch Surg 138:1214-8. 2003
    ..Critical postoperative review of technetium Tc 99m sestamibi scintigraphy can identify an undescended parathyroid adenoma on scans initially interpreted as nondiagnostic or negative...
  17. pmc Factors that influence radioactive iodine use for thyroid cancer
    Maria Papaleontiou
    Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine, University of Michigan Health System, University of Michigan, Ann Arbor, Michigan, USA
    Thyroid 23:219-24. 2013
    ..There is variation in the use of radioactive iodine (RAI) as treatment for well-differentiated thyroid cancer. The factors involved in physician decision-making for RAI remain unknown...
  18. doi request reprint Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48103 5028, USA
    Semin Nucl Med 42:171-84. 2012
    ..Radiolabeled MIBG is an exemplar of theranostics and remains a worthy agent for both diagnosis and therapy of endocrine tumors...
  19. ncbi request reprint Practical dosimetry of 131I in patients with thyroid carcinoma
    James C Sisson
    Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, MI, USA
    Cancer Biother Radiopharm 17:101-5. 2002
    ..With lower levels of prescribed diagnostic 131I, stunning should not impair dosimetry. Thus, readily obtained measurements make dosimetry a practical method for improving carcinoma therapy with 131I...
  20. doi request reprint Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation
    Monica L Marvin
    Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA
    Head Neck 31:689-94. 2009
    ..The recognition of patients with hereditary PGL and identification of the responsible gene are important for the management of index patients and family members...
  21. ncbi request reprint Cryptococcal thyroiditis and hyperthyroidism
    Anca M Avram
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0028, USA
    Thyroid 14:471-4. 2004
    ..Our patient is the first who survived the disseminated cryptococcal infection with thyroid involvement, thus enabling longitudinal clinical and endocrinologic follow-up...
  22. ncbi request reprint Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
    James C Sisson
    Eur J Nucl Med Mol Imaging 34:1129-30. 2007
  23. ncbi request reprint Thyroid carcinoma
    Steven I Sherman
    The University of Texas M D Anderson Cancer Center, USA
    J Natl Compr Canc Netw 5:568-621. 2007
  24. ncbi request reprint Thyroid carcinoma
    Steven I Sherman
    University of Texas M D Anderson Cancer Center, USA
    J Natl Compr Canc Netw 3:404-57. 2005
  25. ncbi request reprint Radiation-induced osteosarcoma and papillary carcinoma of the thyroid
    Adam Tonakie
    Department of South Coast Radiology, Mermaid Beach, Australia
    Clin Nucl Med 31:5-8. 2006
    ..This article describes a patient with dual radiation-induced malignancies after treatment of neuroblastoma...